HSA-approved treatments prescribed by licensed doctors, delivered with complete discretion.
HSA-APPROVED CLINIC
Doctor-supervised weight management combining medical expertise with personalised care. Evidence-based. HSA-compliant. Results that last.
Meet Your Doctor
Not a quick fix. A medically supervised programme tailored to your body, your goals, and your health.
Licensed Family Physician · Registered with Singapore Medical Council
Every treatment plan begins with a comprehensive health assessment — including blood work, metabolic screening, and lifestyle evaluation — to determine the safest and most effective approach for your unique health profile. Your journey is guided by clinical evidence, monitored with regular follow-ups, and adjusted as your body responds. This is medical weight management — not a quick fix.
Medical weight loss uses HSA-approved prescription treatments combined with doctor supervision to target the biological drivers of weight gain. Unlike commercial slimming programmes, medical weight management addresses the hormones that regulate appetite, satiety, and metabolism.
The cornerstone treatment class is GLP-1 receptor agonists. These medications mimic the naturally occurring GLP-1 hormone:
Appetite suppression: Signals the brain that you are full, reducing hunger.
Slowed gastric emptying: Food stays in the stomach longer, prolonging satiety.
Improved insulin sensitivity: Better blood sugar control reduces cravings.
Calorie reduction: Clinical studies show patients naturally consume 25-35% fewer calories.
According to the New England Journal of Medicine (2021), patients on GLP-1 treatment combined with lifestyle modification achieved substantially greater weight reduction than lifestyle modification alone.
Several GLP-1 receptor agonists are available through Singapore healthcare providers. Each has different efficacy profiles:
| Treatment | Active Ingredient | Avg. Weight Reduction | Dosing | HSA Status |
|---|---|---|---|---|
| Wegovy | Semaglutide 2.4mg | 15-20% | Weekly injection | Approved (weight loss) |
| Rybelsus | Semaglutide (oral) | 10-15% | Daily tablet | Approved (diabetes) |
| Saxenda | Liraglutide 3.0mg | 5-10% | Daily injection | Approved (weight loss) |
| Mounjaro | Tirzepatide | 20-25% | Weekly injection | Limited availability |
Source: Clinical trial data published in NEJM (2021), JAMA (2022), HSA Singapore. Individual results vary. Dr. Wang determines the most appropriate treatment during your consultation.
The Ministry of Health uses Asian-specific BMI cutoffs:
| BMI Range (Asian) | Classification | Treatment Eligibility |
|---|---|---|
| < 18.5 | Underweight | Not eligible |
| 18.5-22.9 | Normal | May not qualify |
| 23.0-27.4 | Overweight | Eligible with condition |
| >=27.5 | Obese | Eligible |
According to the MOH National Population Health Survey (2022), 36.2% of Singaporeans aged 18-74 are overweight (BMI >=23). Dr. Wang conducts a thorough medical assessment to determine eligibility.
At NuLifeCare, pricing is transparent:
| Item | Estimated Range (SGD) | Notes |
|---|---|---|
| Initial consultation | FREE | No-obligation telehealth session |
| Weekly GLP-1 injection (monthly) | $350-$500 | Includes medication + delivery |
| Daily oral GLP-1 (monthly) | $250-$400 | Tablet form, includes delivery |
| Follow-up consultation | Included | Regular monitoring |
| Lifestyle & nutrition coaching | Included | Personalised guidance |
The initial consultation is free. All costs discussed transparently before treatment begins.
Step 1 – Initial Telehealth Consultation (Free): Confidential video consultation with Dr. Wang. No commitment.
Step 2 – Medical Assessment: Dr. Wang reviews your health profile, BMI, medications, and conditions.
Step 3 – Personalised Treatment Plan: Dr. Wang recommends a specific GLP-1 treatment and programme.
Step 4 – Treatment Initiation: Medication dispensed and delivered with same-day delivery.
Step 5 – Dose Titration (Weeks 1-16): Gradual dose increase under supervision.
Step 6 – Monthly Follow-ups: Regular check-ins to monitor progress and adjust treatment.
Step 7 – Ongoing Support: Maintenance plan for long-term success.
Results vary. Typical outcomes when treatment is combined with lifestyle modification:
| Timeframe | Typical Weight Reduction | Milestone |
|---|---|---|
| Weeks 1-4 | 2-4 kg | Appetite reduction noticeable |
| Months 2-3 | 5-8 kg | Visible physical changes |
| Months 4-6 | 8-14 kg | Health marker improvements |
| Months 6-12 | 12-20% body weight | Majority of loss achieved |
| 12+ months | 15-20% maintained | Maintenance phase |
NuLifeCare does not guarantee specific outcomes. These ranges reflect clinical data.
GLP-1 treatments are well-studied. Most side effects are mild and decrease as your body adapts:
| Side Effect | Frequency | Management |
|---|---|---|
| Nausea | Very common (40-50%) | Smaller meals; slow dose titration |
| Vomiting | Common (10-15%) | Stay hydrated |
| Diarrhoea | Common (10-20%) | Usually resolves after dose adjustment |
| Constipation | Common (10-15%) | Increase fibre and water |
| Abdominal discomfort | Common (10-15%) | Often temporary |
Serious side effects are uncommon when properly supervised. Dr. Wang monitors at every follow-up.
Sustaining weight loss is as important as achieving it:
Clinical evidence shows patients who continue with medical support during maintenance are significantly more likely to sustain results.
Most patients notice reduced appetite within the first week. Measurable weight loss typically begins by weeks 4-8, with visible changes becoming apparent around months 2-3.
Some private insurers cover doctor consultations. Medication costs are typically out-of-pocket. NuLifeCare provides itemised receipts for insurance claims.
No. NuLifeCare operates entirely through telehealth. All consultations with Dr. Wang are via video call. Medication is delivered to your address.
This decision is made between you and Dr. Wang based on your health profile, preferences, and medical history. Both injectable and oral options are available.
Most side effects are mild and decrease as your body adapts. Dr. Wang monitors you throughout treatment and can adjust your dose or pause the programme if needed.
Treatment should not be stopped abruptly. Dr. Wang transitions patients to a maintenance plan. Stopping suddenly can lead to weight regain.
Commercial centres typically do not employ licensed doctors. NuLifeCare is doctor-led. Treatments are prescribed after medical assessment using HSA-approved medications.
GLP-1 medications have well-established blood sugar benefits. Dr. Wang assesses your full medical profile. The programme complements your existing healthcare.
This page is for informational and educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare professional. NuLifeCare is operated by Nulife Community Care Pte. Ltd. (UEN: 202526802Z). Dr. Joseph Wang is a licensed Family Physician. Individual results vary. GLP-1 treatments are prescription-only. Not suitable for pregnant or breastfeeding women.
Book a free, confidential telehealth consultation with Dr. Joseph Wang. No commitment. No pressure. Just honest, professional medical guidance.
Phone: 6844 1528 | WhatsApp: +65 9846 5594 | contact@nulifecare.com.sg
Blk 325 Ubi Ave 1 #01-701 S(400325)